Given the involvement of MMP-14 in HER2+ cancer cell invasion41–43, it will be interesting to test for the effects of Myc B on Dynactin and MMP-14 activity in these models in future studies aimed at understanding comprehensive effects of actin disruption in metastatic cancers. Here, ERBB2 is linked to metastatic malignant neoplasm.